Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bayer AG buy gerihouse

Start price
€85.44
16.05.13 / 50%
Target price
€90.50
05.08.13
Performance (%)
5.93%
End price
€90.50
05.08.13
Summary
This prediction ended on 05.08.13 with a price of €90.50. With a performance of 5.93%, the BUY prediction by gerihouse for Bayer AG closed with a slight gain. gerihouse has 50% into this prediction

Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.

Performance without dividends (%)
Name 1w 1m 1y 3y
Bayer AG 7.198% 7.198% -49.912% -46.852%
iShares Core DAX® 1.883% 5.122% 21.667% 22.437%
iShares Nasdaq 100 0.125% 2.574% 45.951% 55.507%
iShares Nikkei 225® -0.201% 4.341% 28.806% 9.945%
iShares S&P 500 0.728% 4.141% 34.630% 50.086%

According to gerihouse what are the pros and cons of Bayer AG for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Future proof or reliable business model
High dividend yield expected
Innovative
Good rating
Cons

Comments by gerihouse for this prediction

In the thread Bayer AG diskutieren
Prediction Buy
Perf. (%) 5.93%
Target price 90.500
Change
Ends at 05.08.13

Auf Einkaufstour

Bayer setzt seine Einkaufstour weiter fort. Dazu übernehmen die Leverkusener das Darmstädter Familienunternehmen Steigerwald Arzneimittelwerk GmbH. Steigerwald ist spezialisiert auf apothekenpflichtige Arzneimittel auf pflanzlicher Basis. Über den Kaufpreis wurde Stillschweigen vereinbart. Die Wettbewerbsbehörden müssen dem Geschäft noch zustimmen.

Steigerwald erzielte im vergangenen Jahr einen Umsatz von 61,3 Millionen Euro. Das Unternehmen beschäftigt rund 180 Mitarbeiter. Bayer will alle Steigerwald-Mitarbeiter übernehmen.

Vorstandsvorsitzender Marijn Dekkers hatte seit längerem angekündigt, den Konzern mit ergänzenden Akquisitionen vor allem in der Gesundheits- aber auch in der Agrarsparte stärken zu wollen. Erst kürzlich hatte der Konzern ein Übernahmeangebot über 1,1 Milliarden US-Dollar für das US-Unternehmen Conceptus abgegeben, um sein Verhütungsmittelgeschäft zu stärken.

Im vergangenen Jahr hatte Bayer das Tiermedizingeschäft von Teva sowie das Agrarunternehmen AgraQuest gekauft.

Prediction Buy
Perf. (%) 5.93%
Target price 90.500
Change
Ends at 05.08.13

(Zielkurs erreicht)

Stopped prediction by gerihouse for Bayer AG

buy
Bayer AG

Start price
Target price
Perf. (%)
€49.60
10.01.22
€70.00
10.01.23
3.36%
22.01.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€58.86
04.05.20
€55.00
04.11.21
-15.30%
05.11.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€55.37
06.04.20
€70.00
18.04.20
6.30%
18.04.20

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€60.00
09.03.20
€80.00
16.03.20
-23.30%
16.03.20

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€63.61
14.08.19
€82.00
09.03.20
-5.68%
09.03.20

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€53.21
14.06.19
€89.00
08.07.19
12.65%
08.07.19

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€76.80
12.10.18
€89.00
21.03.19
-20.20%
21.03.19

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€111.80
26.09.17
€130.00
06.09.18
-28.07%
06.09.18

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€107.03
26.01.17
€125.00
07.06.17
12.55%
07.06.17

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€89.85
07.10.16
€98.00
19.12.16
9.10%
19.12.16

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€97.56
08.03.16
€120.00
30.08.16
2.23%
30.08.16

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€123.32
04.11.15
€152.00
08.02.16
-21.77%
08.02.16

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€110.85
07.01.15
€135.00
06.02.15
12.72%
06.02.15

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.02
01.03.12
€60.00
20.06.12
0.22%
20.06.12

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies